2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: A novel powerful and selective inhibitor of protein kinase CK2

Biochemical and Biophysical Research Communications

Volumn 321, Issue 4, 2004, Pages 1040-1044

  Pagano, Mario A ^a   Meggio, Flavio ^a   Ruzzene, Maria ^a   Andrzejewska, Mariola ^b   Kazimierczuk, Zygmunt ^b,c   Pinna, Lorenzo A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Police Academy   (Croatia)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

CK2 inhibitors; DMAT; Polyhalogenated benzimidazoles; Protein kinase CK2; TBB

Indexed keywords

2 DIMETHYLAMINO 4,5,6,7 TETRABROMO 1H BENZIMIDAZOLE; 4,5,6,7 TETRABROMOBENZOTRIAZOLE; BENZIMIDAZOLE DERIVATIVE; CASEIN KINASE II; PHOSPHOTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BENZIMIDAZOLES; CASEIN KINASE II; CASEIN KINASES; ENZYME INHIBITORS; HUMANS; JURKAT CELLS; KINETICS; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; RATS; TRIAZOLES;

EID: 3843114402     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.067     Document Type: Article

References (19)

1. F. Meggio, and L.A. Pinna One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17 2003 349 368
2. D.W. Litchfield Protein kinase CK2: structure, regulation and role in cellular decisions of life and death Biochem. J. 369 2003 1 15
3. D.C. Seldin, and P. Leder Casein kinase IIα transgene-induced murine lymphoma: relation to theilleriosis in cattle Science 267 1995 894 897
4. M.A. Kelliher, D.C. Seldin, and P. Leder Tal-1 induces cell acute lymphoblastic leukemia accelerated by casein kinase IIα EMBO J. 15 1996 5160 5166
5. E. Landesman-Bollag, P.L. Channavajhala, R.D. Cardiff, and D.C. Seldin p53 deficiency and misexpression of protein kinase CK2 alpha collaborate in the development of thymic lymphomas in mice Oncogene 16 1998 2965 2974
6. M. Orlandini, F. Semplici, R. Ferruzzi, F. Meggio, L.A. Pinna, and S. Oliviero Protein kinase CK2alphá is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation J. Biol. Chem. 273 1998 21291 21297
7. S. Tawfic, S. Yu, H. Wang, R. Faust, A. Davis, and K. Ahmed Protein kinase CK2 signal in neoplasia Histol. Histopathol. 16 2001 573 582
8. M. Ruzzene, D. Penzo, and L.A. Pinna Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells Biochem. J. 364 2002 41 47
9. J.I. Loizou, S.F. El-Khamisy, A. Zlatanou, D.J. Moore, D.W. Chan, J. Qin, S. Sarno, F. Meggio, L.A. Pinna, and K.W. Caldecott The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks Cell 117 2004 17 28
10. S. Mishra, A. Reichert, J. Cunnick, D. Senadheera, B. Hemmeryckx, N. Heisterkamp, and J. Groffen Protein kinase CKIIalpha interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cells Oncogene 22 2003 8255 8262
11. S. Sarno, H. Reddy, F. Meggio, M. Ruzzene, S.P. Davies, A. Donella-Deana, D. Shugar, and L.A. Pinna Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ("casein kinase-2") FEBS Lett. 496 2001 44-48
12. M. Andrzejewska, M.A. Pagano, F. Meggio, A.M. Brunati, and Z. Kazimierczuk Polyhalogenobenzimidazoles: synthesis and their inhibitory activity against casein kinases Bioorg. Med. Chem. 11 2003 3997 4002
13. V. Pulgar, O. Marin, F. Meggio, C.C. Allende, J.E. Allende, and L.A. Pinna Optimal sequences for non-phosphate directed phosphorylation by protein kinase CK1 (casein kinase-1)- a re-evaluation Eur. J. Biochem. 260 1999 520 526
14. F. Meggio, A. Donella Deana, and L.A. Pinna Endogenous phosphate acceptor proteins for rat liver cytosolic casein kinases J. Biol. Chem. 256 1981 11958 11961
15. S. Sarno, E. De Moliner, M. Ruzzene, M.A. Pagano, R. Battistutta, J. Bain, D. Fabbro, J. Schoepfer, M. Elliott, P. Furet, F. Meggio, G. Zanotti, and L.A. Pinna Biochemical and 3D-structural data on the specific inhibition of protein kinase CK2 by ((5-oxo-5,6-dihydro-indolo(1,2-a)quinazolin-7-yl)acetic acid) (IQA) Biochem. J. 374 2003 639 646
16. S.P. Davies, H. Reddy, M. Caivano, and P. Cohen Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem. J. 351 2000 95 105
17. J. Bain, H. McLauchlan, M. Elliott, and P. Cohen The specificities of protein kinase inhibitors: an update Biochem. J. 371 2003 199 204
18. V. Fotaki, M. Dierssen, S. Alcantara, S. Martines, E. Martì, C. Casas, J. Visa, E. Soriano, X. Estivill, and M.L. Arbones Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice Mol. Cell. Biol. 22 2002 6636 6647
19. J. Galceran, K. de Graaf, F.J. Tejedor, and W. Becker The MNB/DYRK1a protein kinase: genetic and biochemical properties J. Neural Transm. Suppl. 67 2003 139 148